CH EPL (R5)
1.0.0-ci-build - ci-build Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Dataexport FOPH Spezialitätenliste
... 4 Abrilada
... 5 Cuprior
... 6 Entocort
... 7 Estalis
... 8 Keytruda
... 9 Paxlovid
... 10 Triogen
... 11 Profiles
... 12 Extensions
... 13 Terminology
... 14 Changelog
... 15 Artifacts Summary
.... 15.1 CH EPL Organization
.... 15.2 CH IDMP AdministrableProductDefinition
.... 15.3 CH IDMP ClinicalUseDefinition Indication
.... 15.4 CH IDMP DocumentReference
.... 15.5 CH IDMP ManufacturedItemDefinition
.... 15.6 IDMP Bundle
.... 15.7 IDMP Ingredient
.... 15.8 IDMP MedicinalProductDefinition
.... 15.9 IDMP PackagedProductDefinition
.... 15.10 IDMP RegulatedAuthorization
.... 15.11 FOPH Dossier Number
.... 15.12 GLN Identifier
.... 15.13 LOC Identifier
.... 15.14 CH - EPL Full Limitation Text
.... 15.15 CH - EPL Product Price
.... 15.16 CH - EPL Regulated Authorization Limitation
.... 15.17 CH - EPL Reimbursement SL
.... 15.18 CH - SMC Authorized Dose Form
.... 15.19 CH - Authorisation Type
.... 15.20 CH - Medicinal Product Name Type
.... 15.21 CH - Other Characteristics Type
.... 15.22 CH EPL - Gamme
.... 15.23 CH EPL - Index Therapeuticus
.... 15.24 CH EPL - Limitation Status
.... 15.25 CH EPL - Listing Status
.... 15.26 CH EPL - Other Characteristics Packaged Item
.... 15.27 CH EPL - Price Type
.... 15.28 CH EPL - Product Type
.... 15.29 CH EPL - Reimbursement Status
.... 15.30 CH EPL - Type of Price Change
.... 15.31 CH SMC - Additional Monitoring Indicator
.... 15.32 CH SMC - Attached Document Type
.... 15.33 CH SMC - Authorisation Category
.... 15.34 CH SMC - Authorisation Status
.... 15.35 CH SMC - Authorised Pharmaceutical Dose Form
.... 15.36 CH SMC - Ingredient Role
.... 15.37 CH SMC - Legal Status of Supply
.... 15.38 CH SMC - Marketing Status
.... 15.39 CH SMC - Pediatric Use Indicator
.... 15.40 CH SMC - Special Precautions for Storage
.... 15.41 CH SMC - Substance
.... 15.42 CH SMC - TherapeuticProductcode
.... 15.43 EDQM - Combination Packaging
.... 15.44 EDQM - Combined Pharmaceutical Dose Form
.... 15.45 EDQM - Combined Term
.... 15.46 EDQM - Packaging
.... 15.47 EDQM - Pharmaceutical Dose Form
.... 15.48 EDQM - Route Of Administration
.... 15.49 EDQM - Unit of Presentation
.... 15.50 EMA - Domain
.... 15.51 EMA - Intended Effect
.... 15.52 EMA - Shelf Life Type
.... 15.53 CH - Authorisation Type
.... 15.54 CH - Medicinal Product Name Type
.... 15.55 CH - Other Characteristics Type
.... 15.56 CH EPL - Gamme
.... 15.57 CH EPL - Index Therapeuticus
.... 15.58 CH EPL - Limitation Status
.... 15.59 CH EPL - Listing Status
.... 15.60 CH EPL - Other Characteristics Packaged Item
.... 15.61 CH EPL - Price Type
.... 15.62 CH EPL - Product Type
.... 15.63 CH EPL - Reimbursement Status
.... 15.64 CH EPL - Type of Price Change
.... 15.65 CH SMC - Additional Monitoring Indicator
.... 15.66 CH SMC - Attached Document Type
.... 15.67 CH SMC - Authorisation Category
.... 15.68 CH SMC - Authorisation Status
.... 15.69 CH SMC - Ingredient Role
.... 15.70 CH SMC - Legal Status of Supply
.... 15.71 CH SMC - Marketing Status
.... 15.72 CH SMC - Pediatric Use Indicator
.... 15.73 CH SMC - Special Precautions for Storage
.... 15.74 CH SMC - Substance
.... 15.75 CH SMC - TherapeuticProductcode
.... 15.76 EDQM - Standard Terms
.... 15.77 EMA - Domain
.... 15.78 EMA - Intended Effect
.... 15.79 EMA - Shelf Life Type
.... 15.80 Application / Assessment Tracking Number
.... 15.81 Clinical Product Identifier
.... 15.82 FOPH Dossier Number
.... 15.83 GLN Identifier
.... 15.84 Global Trade Item Number
.... 15.85 LOC Identifier
.... 15.86 Marketing Authorisation Number
.... 15.87 Medical Product Identifier
.... 15.88 Pharmaceutical Product Identifier
.... 15.89 5204201
.... 15.90 52042011
.... 15.91 5470402
.... 15.92 54704089
.... 15.93 66231001
.... 15.94 6623101
.... 15.95 67431001
.... 15.96 6743101
.... 15.97 67719001
.... 15.98 6771901
.... 15.99 67831001
.... 15.100 67831001
.... 15.101 6783101
.... 15.102 68793001
.... 15.103 6879301
.... 15.104 ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml (Bundle)
.... 15.105 Abrilada, Injektionslösung
.... 15.106 Abrilada, Injektionslösung Fachinformation
.... 15.107 Abrilada, Injektionslösung Fachinformation
.... 15.108 CH-52042011
.... 15.109 CH-54704089
.... 15.110 CH-66231001
.... 15.111 CH-67431001
.... 15.112 CH-67831001
.... 15.113 CH-67831002
.... 15.114 CH-68291001
.... 15.115 CH-68793001
.... 15.116 CUPRIOR Filmtabl 150 mg (Bundle)
.... 15.117 CUPRIOR Filmtabl 150 mg 72 Stk
.... 15.118 Cuprior, Filmtabletten Fachinformation
.... 15.119 Cuprior, Filmtabletten Patienteninformation
.... 15.120 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 15.121 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 15.122 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 15.123 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 15.124 ESTALIS Matrixpfl 50/250 24 Stk
.... 15.125 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 15.126 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 15.127 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 15.128 Indication 10002556
.... 15.129 Indication 10003268
.... 15.130 Indication 10009900
.... 15.131 Indication 10019927
.... 15.132 Indication 10020041
.... 15.133 Indication 10021782
.... 15.134 Indication 10027400
.... 15.135 Indication 10028881
.... 15.136 Indication 10030247
.... 15.137 Indication 10031285
.... 15.138 Indication 10037153
.... 15.139 Indication 10037160
.... 15.140 Indication 10043971
.... 15.141 Indication 10045365
.... 15.142 Indication 10046851
.... 15.143 Indication 10061091
.... 15.144 Indication 10075566
.... 15.145 Indication 10084529
.... 15.146 Indication 10089182
.... 15.147 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 15.148 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 15.149 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 15.150 Limitation 156370009
.... 15.151 Limitation 254837009
.... 15.152 Limitation 34000006
.... 15.153 Limitation 59393003
.... 15.154 Limitation 64766004
.... 15.155 Limitation 69896004
.... 15.156 Limitation 79886009
.... 15.157 Limitation 840539006
.... 15.158 Limitation 9014002
.... 15.159 Limitation 9631008
.... 15.160 MI Abrilada-40mg-Pre-Filled-Pen
.... 15.161 MI Budesonidum-2.3mg-Tablet
.... 15.162 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 15.163 MI Nirmatrelvir-150mg-Tablet
.... 15.164 MI Pembrolizumab-100mg-Vial
.... 15.165 MI Ritonavirum-100mg-Tablet
.... 15.166 MI Solvent
.... 15.167 MI Trientinum-150mg-Tablet
.... 15.168 MI Trientinum-250mg-Capsule
.... 15.169 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 15.170 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 15.171 Paxlovid, Filmtabletten Patienteninformation
.... 15.172 PhP Abrilada-40mg-Pre-Filled-Pen
.... 15.173 PhP Budesonidum-Suspension
.... 15.174 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 15.175 PhP Pembrolizumab-100mg-Vial
.... 15.176 PhP Trientinum-150mg-Tablet
.... 15.177 PhP Trientinum-150mg-Tablet
.... 15.178 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 15.179 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 15.180 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 15.181 Reimbursement SL 17418
.... 15.182 Reimbursement SL 17973
.... 15.183 Reimbursement SL 20416
.... 15.184 Reimbursement SL 21070
.... 15.185 Reimbursement SL 21203 1 Pre-Filled Pen
.... 15.186 Reimbursement SL 21203 2 Pre-Filled Pen
.... 15.187 Reimbursement SL 21208
.... 15.188 Reimbursement SL 21529
.... 15.189 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 15.190 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 15.191 Triogen, Kapseln Fachinformation
.... 15.192 Triogen, Kapseln Patienteninformation